戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 o contribute to the biochemical pathology of X-linked adrenoleukodystrophy.
2 from the inflammatory cerebral phenotypes of X-linked adrenoleukodystrophy.
3  commonly involved in cerebral phenotypes of X-linked adrenoleukodystrophy.
4 mplicates this enzyme in the pathogenesis of X-linked adrenoleukodystrophy.
5         The childhood-onset cerebral form of X-linked adrenoleukodystrophy, a demyelinating disorder
6                                              X-linked adrenoleukodystrophy (ALD) is a devastating inh
7                                              X-linked adrenoleukodystrophy (ALD) is a progressive neu
8                                              X-linked adrenoleukodystrophy (ALD) may switch phenotype
9                                              X-linked adrenoleukodystrophy (ALD) usually presents in
10 f 4PBA or HU in two distinct disease models, X-linked adrenoleukodystrophy and sickle cell disease.
11 c chondrodysplasia punctata, Refsum disease, X-linked adrenoleukodystrophy, and deficiency of mitocho
12 enomyeloneuropathy is the late-onset form of X-linked adrenoleukodystrophy, and is considered the mos
13 s, pathogenesis, diagnosis and prevention of X-linked adrenoleukodystrophy, and therapies are emergin
14 which accumulate in tissues of patients with X-linked adrenoleukodystrophy, are activated by very lon
15 n and spectroscopy have been well studied in X-linked adrenoleukodystrophy, but no data exist on magn
16 ral adrenoleukodystrophy is a severe form of X-linked adrenoleukodystrophy characterized by white-mat
17 evels were partially restored in transfected X-linked adrenoleukodystrophy fibroblasts regardless of
18                           The gene defect in X-linked adrenoleukodystrophy has been firmly establishe
19                                              X-linked adrenoleukodystrophy has two distinct neurologi
20 12 patients with childhood onset of cerebral X-linked adrenoleukodystrophy have been followed for 5-1
21                                     Cerebral X-linked adrenoleukodystrophy is a devastating neurodege
22      The adult cerebral inflammatory form of X-linked adrenoleukodystrophy is a rapidly progressive n
23                                              X-linked adrenoleukodystrophy is a severe demyelinating
24                                              X-linked adrenoleukodystrophy is caused by mutations in
25  for a scientific commentary on this article.X-linked adrenoleukodystrophy is caused by mutations in
26                  The biochemical hallmark of X-linked adrenoleukodystrophy is the accumulation of ver
27        Animal models have been developed for X-linked adrenoleukodystrophy, metachromatic leukodystro
28                   Heterozygous women and the X-linked adrenoleukodystrophy mouse model often have the
29                                           In X-linked adrenoleukodystrophy, mutations in ABCD1 lead t
30 ty rule out a likely role for this enzyme in X-linked adrenoleukodystrophy pathology.
31  model resembles that observed in cells from X-linked adrenoleukodystrophy patients.
32 to enhanced GFP in human skin fibroblasts of X-linked adrenoleukodystrophy patients.
33 class with significant identity to the human X-linked adrenoleukodystrophy protein (ALDP).
34                                              X-linked adrenoleukodystrophy, representing the other gr
35 of 12 patients with childhood-onset cerebral X-linked adrenoleukodystrophy shows the long-term benefi
36 eview and evaluate the new information about X-linked adrenoleukodystrophy that has been reported in
37    Mutations in the gene encoding ALDP cause X-linked adrenoleukodystrophy; the role of ALDR and PMP7
38  noninflammatory myeloneuropathic variant of X-linked adrenoleukodystrophy, where the disease process
39    The most frequent peroxisomal disorder is X-linked adrenoleukodystrophy, which is caused by mutati
40 t widely used procedure for the diagnosis of X-linked adrenoleukodystrophy (X-ALD) and other peroxiso
41 tive was to study the phenotype evolution of X-linked adrenoleukodystrophy (X-ALD) and the relation b
42 usion tensor imaging (DTI), in children with X-linked adrenoleukodystrophy (X-ALD) before and after h
43 orescence assay, we determined the number of X-linked adrenoleukodystrophy (X-ALD) hemizygotes from t
44                                     Cerebral X-linked adrenoleukodystrophy (X-ALD) is a disorder of v
45                                              X-linked adrenoleukodystrophy (X-ALD) is a neurodegenera
46                                              X-linked adrenoleukodystrophy (X-ALD) is a neurodegenera
47                                              X-Linked adrenoleukodystrophy (X-ALD) is a neurodegenera
48                                              X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal d
49                                              X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal d
50                                              X-linked adrenoleukodystrophy (X-ALD) is associated with
51                The neurodegenerative disease X-linked adrenoleukodystrophy (X-ALD) is characterized b
52                                              X-linked adrenoleukodystrophy (X-ALD) is characterized b
53                             Mutations in the X-linked adrenoleukodystrophy (X-ALD) protein cause accu
54                                              X-linked adrenoleukodystrophy (X-ALD) results from mutat
55                                              X-linked adrenoleukodystrophy (X-ALD), a potentially fat
56                                              X-linked adrenoleukodystrophy (X-ALD), an inherited pero
57                                              X-linked adrenoleukodystrophy (X-ALD), the most frequent
58 enoleukodystropy protein (ALDP) defective in X-linked adrenoleukodystrophy (X-ALD).
59 dergo cell death leading to demyelination in X-linked adrenoleukodystrophy (X-ALD).